IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Jazz Pharmaceuticals PLC

CUSIP: 00B4Q5ZN4 | 8 institutional holders

Quarters

Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2024

DnB Asset Management AS9,693
0.0% of portfolio›$1.2M
StyleTurnoverLocationFiled
DnB Asset Management AS
9,693$1.2M0.0%CoreMediumOslo, Norway2024-04-12